Analysis of Ag-presenting cells in the conjunctiva during the development of experimental immune-mediated blepharoconjunctivitis

Current Eye Research

Volumn 29, Issue 4-5, 2004, Pages 277-286

  Ozaki, Akemi ^a   Fukushima, Atsuki ^a   Ishida, Waka ^a   Zinchuk, Olga ^a   Fukata, Kazuyo ^a   Hayashi, Yoshihiro ^a   Enzan, Hideaki ^a   Takata, Masaru ^a   Yagita, Hideo ^b   Ueno, Hisayuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCLONAL ANTIBODY; OVALBUMIN;

ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BLEPHARITIS; CELL SPECIFICITY; CONJUNCTIVITIS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; WESTERN BLOTTING;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD86; BLEPHARITIS; BLOTTING, WESTERN; CELL COUNT; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MODELS, THEORETICAL; OVALBUMIN; PHOSPHORYLATION; RATS; RATS, INBRED BN; T-LYMPHOCYTES;

EID: 19944428441     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490516873     Document Type: Article

References (30)

1. Fukushima A, Yoshida H, Iwamoto H, Yoshida O, Ueno H. The role of cellular immunity both in the induction and effector phases of experimental allergic blepharoconjunctivitis (EAC) in rats. Exp Eye Res. 1997;65: 631-637.
2. Yoshida H, Yoshida O, Iwamoto H, Nishino K, Hashida M, Fukushima A, Ueno H. Analysis of effects of stimulation in vitro of ovalbumin (OVA) primed lymph node cells on adoptive transfer of experimental immune-mediated blepharoconjunctivitis (EC) in Lewis rats. Br J Ophthalmol. 1998;82:1189-1194.
3. Fukushima A, Nishino K, Yoshida O, Ueno H. Characterization of the immunopathogenic responses to ovalbumin (OVA) peptide 323-339 in experimental immune-mediated blepharoconjunctivitis (EC) in Lewis rats. Curr Eye Res. 1998;17:763-769.
4. Yoshida O, Yoshida H, Iwamoto H, Nishino K, Fukushima A, Ueno H. Comparison of genetic susceptibility to experimental allergic blepharo-conjunctivitis (EAC) between Lewis and Fischer rats. Graefe'sArch Clin Exp Ophthalmol. 1998;236:859-864.
5. Yoshida O, Yoshida H, Iwamoto H, Nishino K, Fukushima A, Ueno H. Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr Eye Res. 1999;18: 117-124.
6. Iwamoto H, Nishino K, Magone TM, Whitcup SM, Yoshida O, Yoshida H, Ozaki A, Fukushima A, Ueno H. Experimental immune-mediated blepharoconjunctivitis (EC) in rats induced by immunization with ragweed pollen (RW). Graefe's Arch Clin Exp Ophthalmol. 2000;238:346-351.
7. Ozaki A, Fukushima A, Fukata K, Ueno H. Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats. Clin Exp Immunol. 2000;122:28-34.
8. Fukushima A, Fukata K, Ozaki A, Takata M, Kuroda N, Enzan H, Ueno H. Exertion of the suppressive effects of IFN-γ on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase. Br J Ophthalmol. 2002;86: 1166-1171.
9. Ozaki A, Fukushima A, Fukata K, Ueno H. Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharoconjunctivitis. Graefe's Arch Clin Exp Ophthalmol. 2003;241:394-402.
10. Fukushima A, Ozaki A, Fukata K, Ishida W, Ueno H. Ag-specific recognition, activation and effector function of T cells in the conjunctiva developing experimental immune-mediated blepharoconjunctivitis. Invest Ophthalmol Vis Sci. 2003;44:4366-4374.
11. Trocme SD, Sra KK. Spectrum of ocular allergy. Curr Opin Allergy Clin Immunol. 2002;2:423-427.
12. Katelaris CH. Ocular allergy: Implications for the clinical immunologist. Ann Allergy Asthma Immunol. 2003;90: 23-27.
13. Bhan AK, Fujikawa LS, Foster CS. T-cell subsets and Langerhans cells in normal and diseased conjunctiva. Am J Ophthalmol. 1982;94:205-212.
14. Foster CS, Rice BA, Dutt JE. Immunopathology of atopic keratoconjunctivitis. Ophthalmol. 1991;98:1190-1196.
15. Choi TH, Ko MK, Choe JK. Increased numbers of Langerhans cell and expression of HLA-Dr antigen in the giant papilla of patients with giant papillary conjunctivitis. Korean J Ophthalmol. 1996;10:18-23.
16. Tesavibul N, Dorfman D, Sangwan VS, Christen W, Panayotis Z, Rqjas B, Foster CS. Costimulatory molecules in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci. 1998;39:982-988.
17. Bernauer W, Wright P, Dart JK, Leonard JN, Lightman S. The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis. Ophthalmol. 1993;100:339-346.
18. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunol. 1985;54:589-599.
19. Brenan M, Puklavec M. The MRC OX-62 antigen: A useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J Exp Med. 1992;175:1457-1465.
20. Maeda K, Sato T, Azuma M, Yagita H, Okumura K. Characterization of rat CD80 and CD86 by molecular cloning and mAb. Int Immunol. 1997;9:993-1000.
21. Kawamoto T, Shimizu M. A method for preparing 2- to 50-micron-thick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem Cell Biol. 2000;113:331-339.
22. El-Asrar AM, Struyf S, Al-Kharashi SA, Missotten L, Van Damme J, Geboes K. Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis. Br J Ophthalmol. 2002;86:1175-1180.
23. Leonardi A, DeFranchis G, Zancanaro F, Crivellari G, De Paoli M, Plebani M, Secchi AG. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest Ophthalmol Vis Sci. 1999;40:3036-3040.
24. Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med. 1986;163:903-921.
25. Abu-El-Asrar AM, Tabbara KF, Geboes K, Missotten L, Desmet V. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis. Am J Ophthalmol. 1996;121:156-161.
26. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225-52.
27. Abu-El-Asrar AM, Al-Kharashi SA, Al-Mansouri S, Missotten L, Geboes K. Langerhans' cells in vernal keratoconjunctivitis express the costimulatory molecule B7-2 (CD86), but not B7-1 (CD80). Eye. 2001;15:648-654.
28. Chen H, Hendricks RL. B7 costimulatory requirements of T cells at an inflammatory site. J Immunol. 1998;160: 5045-5052.
29. Watts TH, DeBenedette MA. T cell co-stimulatory molecules other than CD28. Curr Opin Immunol. 1999;11: 286-293.
30. Shelburne CP, Ryan JJ. The role of Th2 cytokines in mast cell homeostasis. Immunol Rev. 2001;179:82-93.